Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-31

Clinical Trial Update: MDT-2113 Drug-Eluting Balloon vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery [NA]

View source ↗

Summary

A clinical trial comparing MDT-2113 Drug-Eluting Balloon with standard percutaneous transluminal angioplasty for atherosclerotic lesions in the superficial femo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MDT-2113 Drug-Eluting Balloon

Snippet

Sponsor: Medtronic Endovascular | Conditions: Femoral Artery Stenosis, Popliteal Artery Stenosis | NA | Status: COMPLETED